Firm Advises on Transparent Interactions With HCPs

  • Life Sciences

The team advised a global pharmaceutical giant Novo Nordisk on various matters relating to compliant and transparent interactions with healthcare professionals and healthcare organizations in Ukraine. Among other things the experts at Marchenko Danevych advised the Client on the implementation of the disclosure requirement, promoted by European Federation of Pharmaceutical Industries and Associations (EFPIA) and Association of Pharmaceutical Research & Development (APRaD).

This site uses cookies. An explanation of their purpose can be found within Terms of Use